Active Ingredient(s):Daunorubicin Liposomal FDA Approved: * April 8, 1996 Pharm Company: *GILEAD Category:Cancer
Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer. Specifically it is used for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma. It is used by injection into a vein. A liposomal formulation known as liposomal daunorubicin also exists.
Common side effects include hair loss, vomiting, bone marrow suppression...
* May have multiple approval dates, manufacturers, or labelers.